{"name": "Coronado Biosciences",
 "permalink": "coronado-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/coronado-biosciences",
 "homepage_url": "http://www.coronadobiosciences.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@coronadobiosciences.com",
 "phone_number": "(206) 826-7168",
 "description": "",
 "created_at": "Sat Jul 17 02:10:28 UTC 2010",
 "updated_at": "Tue Jun 12 14:43:00 UTC 2012",
 "overview": "\u003Cp\u003ECoronado Biosciences, Inc. operates as a biopharmaceutical company. Its products include Oral Pan-BCL-2 Inhibitors, which is used in oral therapy for treating cancer; Anthracycline, used to treat hematologic and epithelial cancers; and NK Cell Activator that is used for eliminating minimal residual disease.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0009/3897/93897v8-max-150x150.jpg"],
     [[250,
       76],
      "assets/images/resized/0009/3897/93897v8-max-250x250.jpg"],
     [[389,
       119],
      "assets/images/resized/0009/3897/93897v8-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "RJ",
      "last_name": "Tesi",
      "permalink": "rj-tesi",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$51.3M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://onbiovc.com/coronado-biosciences-inc-series-c-39m/",
    "source_description": "Coronado Biosciences, Inc.: Series C $3.9M",
    "raised_amount": 3900000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 16,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.prnewswire.com/news-releases/coronado-biosciences-inc-announces-completion-of-financings-management-changes-and-development-update-106636923.html",
    "source_description": "Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update",
    "raised_amount": 21600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 3,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.reuters.com/article/2011/07/06/idUS194650+06-Jul-2011+PRN20110706",
    "source_description": "Coronado Biosciences Closes $25.8M in Series C Financing",
    "raised_amount": 25800000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 7,
    "funded_day": 6,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1700 Seventh Avenue",
    "address2": "Suite 2100",
    "zip_code": " 98101",
    "city": "Seattle",
    "state_code": "WA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null},
   {"description": "",
    "address1": "101 California St",
    "address2": "Suite 2450",
    "zip_code": "94111",
    "city": "San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}